查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
雙特異性抗體市場:各產品類型，各用途，各適應症，各國，各地區- 產業分析，市場規模，市場佔有率，2023-2030年預測
市場調查報告書
商品編碼
1320179

雙特異性抗體市場:各產品類型，各用途，各適應症，各國，各地區- 產業分析，市場規模，市場佔有率，2023-2030年預測

Bispecific Antibody Market with COVID-19 Impact Analysis, By Product Type, By Application, By Indication, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 258 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2022年雙特異性抗體市場規模將達6.309億美元，2023年至2030年複合年增長率為8.3%

雙特異性抗體市場 - 市場動態：

全球癌症負擔的增加和有效治療方法的缺乏預計將推動雙特異性抗體市場的成長。

癌症是一個重大的全球健康問題，其負擔持續增加。儘管癌症治療和護理取得了進展，但缺乏治癒性治療仍然令人擔憂。一種有前景的癌症免疫治療方法是使用雙特異性抗體。據世界衛生組織 (WHO) 稱，癌症是全球頭號死亡原因，預計 2020 年將促使近 1,000 萬人死亡。雙特異性抗體的優點是能夠同時或依序鎖定多個抗原，可以與化療、小分子、檢查點抑制劑等免疫調節藥物合併使用。研發活動的增加可能會創造市場成長機會。然而，與藥物開發相關的高成本阻礙了市場成長。

雙特異性抗體市場 - 主要見解：

  • 由於永續成長意識不斷增強，雙特異性抗體產業預計將大幅成長
  • 按產品類型劃分，癌症將在 2022 年佔最大的市場佔有率
  • 有跡象表明，Katumaxomab將成為2022年的主要類型。
  • 按地區劃分，北美將成為 2022 年收入的主要市場

雙特異性抗體市場 - 區隔分析：

雙特異性抗體的全球市場根據適應症、產品類型、用途和地區進行區隔。

市場依適應症分為三類：癌症、發炎/自體免疫疾病和其他。癌症在市場上佔主導地位。雙特異性抗體作為免疫治療劑已顯示出巨大的潛力，有可能增強人體對癌細胞的免疫反應。雙特異性抗體用於特異性靶向癌細胞或修飾免疫細胞以更有效地識別和對抗癌細胞。

市場依產品類型分為兩類：Blinatumomab、Catumaxomab、Duligotumab 等。卡妥索單抗在市場上佔主導地位，預計在預測期內將保持其主導地位。卡妥馬索單抗是已用於癌症治療的雙特異性抗體的一個具體例子。Katumaxomab 是一種三功能抗體，開發用於治療惡性腹水（癌細胞在腹腔積聚且體液積聚的病症）。

市場依應用分為兩類：醫院、專科診所和其他。醫院處於癌症治療的最前沿，通常在提供雙特異性抗體等尖端藥物方面發揮關鍵作用。專注於癌症治療或免疫療法的專科診所也可能參與雙特異性抗體的施用。

雙特異性抗體市場 - 地理洞察：

從地理來看，該市場遍佈北美、拉丁美洲、歐洲、亞太地區、中東和非洲地區。這些地區根據其經營所在的國家進一步劃分。北美因其大量癌症（包括肺癌、前列腺癌、乳腺癌和子宮頸癌）而在雙特異性抗體市場佔主導地位。這些癌症是雙特異性抗體的潛在標靶，並且正在推動該地區對此類療法的需求。美國國家癌症研究所預測，2020年，美國將有1,806,590人新診斷出癌症，606,520人將死於癌症。此外，由於對標靶和個人化治療的需求不斷增長以及新的雙特異性抗體形式和技術的出現，預計歐洲和亞太地區對雙特異性抗體市場的需求將增加。

雙特異性抗體市場 - 競爭格局：

雙特異性抗體市場競爭激烈，每家公司都以爭奪市場佔有率和監管批准為目標。雙特異性抗體的開發引起了製藥和生物技術行業的極大興趣，市場競爭日益加劇。許多公司正在資助研究和開發，以創造針對多種癌症和其他疾病的新型雙特異性抗體候選物。隨著越來越多的研究支持雙特異性抗體的實用性，人們對開發和使用這些治療方法治療各種類型癌症的興趣與日俱增。一些製藥和生物技術公司正在投資研發以產生自己的雙特異性抗體志工。這促使越來越多的公司競相將有效的雙特異性抗體療法推向市場。公司正在透過優化雙特異性抗體設計、改進製造流程以及探索聯合療法來提高療效，從而使他們的產品脫穎而出。例如，安進 (Amgen) 和 Xencor, Inc. 最近宣布了一項研究和許可協議，以開發和商業化癌症免疫療法和炎症的新療法。此次合作將 Amgen 在標靶發現和蛋白質治療方面的能力與 Xencor 的 XmAb 雙特異性技術平台結合。

目錄

第1章 雙特異性抗體市場概要

  • 調查範圍
  • 市場估計年數

第2章 摘要整理

  • 市場明細
  • 競爭考察

第3章 雙特異性抗體的主要市場趨勢

  • 雙特異性抗體推動市場要素
  • 雙特異性抗體阻礙市場要素
  • 雙特異性抗體市場機會
  • 雙特異性抗體市場今後趨勢

第4章 雙特異性抗體產業的調查

  • PEST分析
  • 波特的五力分析
  • 成長預測的製圖
  • 法規結構的分析

第5章 雙特異性抗體市場:COVID-19影響分析

  • COVID-19前的影響分析
  • COVID-19後的影響分析

第6章 雙特異性抗體市場形勢

  • 雙特異性抗體市場佔有率分析，2022年
  • 各主要製造商的明細資料
    • 現有企業的分析
    • 新興企業的分析

第7章 雙特異性抗體市場-各產品類型

  • 概要
    • 各產品類型的市場區隔佔有率分析
    • Blinatumomab
    • Catumaxomab
    • Duligotumab
    • 其他

第8章 雙特異性抗體市場- 各用途

  • 概要
    • 各用途的市場區隔佔有率分析
    • 醫院
    • 專門診所
    • 其他

第9章 雙特異性抗體市場- 各適應症

  • 概要
    • 各適應症各市場區隔佔有率分析
    • 癌症
    • 發炎性·自體免疫疾病
    • 其他

第10章 雙特異性抗體市場-各地區

  • 簡介
  • 北美
    • 概要
    • 主要製造商
    • 美國
    • 加拿大
  • 歐洲
    • 概要
    • 主要製造商
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 其他
  • 亞太地區(APAC)
    • 概要
    • 主要製造商
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 其他
  • 南美
    • 概要
    • 主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他
  • 中東和非洲
    • 概要
    • 主要製造商
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 其他

第11章 主要供應商分析- 雙特異性抗體產業

  • 競爭儀表板
  • 企業簡介
    • Genmab
    • Merus
    • Chugai Pharmaceutical
    • Ablynx
    • Genentech
    • Jounce Therapeutics
    • Affimed Therapeutics
    • Eli Lilly
    • AstraZeneca(MedImmune)
    • Neovii Biotech
    • Pieris
    • Adimab
    • Immunomedics
    • Roche
    • Amgen
    • Sanofi
    • Emergent BioSolutions
    • NovImmune SA
    • Regeneron Pharmaceuticals
    • EMD Serono
    • OncoMed Pharmaceuticals
    • MacroGenicsC

第12章 分析師的全方位展望

Product Code: ANV1490

REPORT HIGHLIGHT

Bispecific Antibody Market size was valued at USD 630.9 Million in 2022, expanding at a CAGR of 8.3% from 2023 to 2030.

Bispecific antibodies aim to treat multi-layered, complex diseases by engaging two disease targets with one molecule. They are synthetic hybrid molecules having two separate binding domains that target two unique antigens, as opposed to natural antibodies, which have two targeting arms that attach to the same target antigen. Bispecific antibodies are typically not found in nature but are instead created using recombinant DNA techniques or cell fusion. By focusing on two distinct disease pathways, bispecific antibodies have the potential to increase therapeutic efficacy in the treatment of complicated human diseases.

Bispecific Antibody Market- Market Dynamics:

The rising global burden of cancer and the unavailability of effective curing drugs possess are expected to propel the growth of the Bispecific Antibody Market.

Cancer is a significant global health challenge, and its burden continues to rise. While advances in cancer treatment and care have been made, the lack of viable curative treatments remains a concern. One promising approach to cancer immunotherapy is the use of Bispecific Antibodies. According to the world health organization, Cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020. Bispecific antibodies have the benefit of being able to target numerous antigens simultaneously and sequentially, and they can be employed in conjunction with chemotherapy, small compounds, and immunomodulatory medicines like checkpoint inhibitors. An increase in the number of research and development activities can provide growth opportunities for the market. However, the High cost associated with drug development hampers the market growth.

Bispecific Antibody Market- Key Insights:

  • As per the analysis shared by our research analyst, the global Bispecific Antibody market is estimated to grow annually at a CAGR of around 8.3% over the forecast period (2023-2030)
  • The Bispecific Antibody industry is projected to grow at a significant rate due to the growing awareness of sustainable growth
  • Based on Product Type segmentation, Cancer was predicted to show maximum market share in the year 2022
  • Based on Indication segmentation, Catumaxomab was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Bispecific Antibody Market- Segmentation Analysis:

The Global Bispecific Antibody Market is segmented on the basis of Indication, Product Type, Application, and Region.

The market is divided into three categories based on Indication: Cancer, Inflammatory & Autoimmune Disorders, and Others. Cancer dominates the market. Bispecific antibodies have shown tremendous potential as immunotherapeutic medicines with the potential to enhance the body's immune response against cancer cells. They can be employed to specifically target cancer cells or modify immune cells to more effectively recognize and battle cancer cells.

The market is divided into two categories based on Product Type: Blinatumomab, Catumaxomab, Duligotumab, and Others. Catumaxomab dominates the market and is likely to maintain its dominance during the forecast period. Catumaxomab is a specific example of a bispecific antibody that has been used in cancer treatment. It is a trifunctional antibody that was developed for the treatment of malignant ascites, a condition where cancerous cells accumulate in the abdominal cavity and lead to fluid buildup.

The market is divided into two categories based on application: Hospitals, Specialty Clinics, and Others. Hospitals are on the cutting edge of cancer care and frequently play a crucial part in delivering cutting-edge medicines like bispecific antibodies. Specialty clinics that focus on cancer care or immunotherapy may also be involved in administering bispecific antibodies.

Bispecific Antibody Market- Geographical Insights:

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America dominates the Bispecific Antibody market due to the highest numbers of several cancers such as lung cancer, prostate cancer, breast cancer, and cervical cancer. These cancers are potential targets for bi-specific antibodies, driving the demand for such therapies in the region. National cancer institute predicted that in 2020, an estimated 1,806,590 new cases of cancer will be diagnosed in the United States and 606,520 people will die from the disease. Furthermore, Europe and Asia Pacific are projected to demand for Bispecific Antibody Market, due to the growing demand for targeted and personalized therapies and the emergence of novel bispecific antibody formats and technologies.

Bispecific Antibody Market- Competitive Landscape:

Bispecific antibody markets are highly competitive, with businesses aiming for market share and regulatory approvals for their goods. Bispecific antibody development has attracted significant interest from the pharmaceutical and biotechnology industries, raising market competition. Numerous companies have been funding research and development to create novel bispecific antibody candidates that focus on various cancers and other diseases. As more research supports the benefits of Bispecific antibodies, there is a growing interest in developing and utilizing these therapies for various types of cancer. Several pharmaceutical companies and biotechnology firms are investing in research and development to create their own Bispecific antibody applicants. This has led to an increase in the number of companies competing to bring effective Bispecific Antibody therapies to the market. Companies are striving to differentiate their products by optimizing the design of Bispecific Antibody, improving manufacturing processes, and exploring combination therapies to enhance their effectiveness. For Instance, Amgen and Xencor, Inc. announced nowadays that the two companies have entered into a research and license agreement to develop and commercialize novel therapeutics in the areas of cancer immunotherapy and inflammation. The research collaboration brings together Amgen's capabilities in target discovery and protein therapeutics with Xencor's XmAb bispecific technology platform.

Recent Developments:

Dec. 19, 2022, Biogen Inc. announced that it has reached an agreement with Genentech, a member of the Roche Group, related to the commercialization and sharing of economics for glofitamab. Under the terms of the agreement, Biogen will have no payment obligations and will receive tiered royalties on potential net sales of glofitamab within the United States as part of the company's long-standing collaboration on antibodies targeting CD20.

Key features of the study:

  • This proposed research study on the Bispecific Antibody market provides market size (US$ Million), compound annual growth rate (CAGR %), and forecast estimation (2023-2030), considering 2022 as the base year
  • The report provides the client the latest up-to-date and trending insights about the Bispecific Antibody market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Bispecific Antibody market
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Bispecific Antibody market
  • Impact of COVID-19 on Bispecific Antibody market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Bispecific Antibody market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the Bispecific Antibody market, we have also included competitive landscape and key innovator analysis for the Bispecific Antibody market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Bispecific Antibody market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global Bispecific Antibody market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BISPECIFIC ANTIBODY MARKET KEY PLAYERS

  • Genmab
  • Merus
  • Chugai Pharmaceutical
  • Ablynx
  • Genentech
  • Jounce Therapeutics
  • Affimed Therapeutics
  • Eli Lilly
  • AstraZeneca (MedImmune)
  • Neovii Biotech
  • Pieris
  • Adimab
  • Immunomedics
  • Roche
  • Amgen
  • Sanofi
  • Emergent BioSolutions
  • NovImmune SA
  • Regeneron Pharmaceuticals
  • EMD Serono
  • OncoMed Pharmaceuticals
  • MacroGenicsC

GLOBAL BISPECIFIC ANTIBODY MARKET, BY INDICATION

  • Cancer
  • Inflammatory & Autoimmune Disorder
  • Others

GLOBAL BISPECIFIC ANTIBODY MARKET, BY PRODUCT TYPE

  • Blinatumomab
  • Catumaxomab
  • Duligotumab
  • Others

GLOBAL BISPECIFIC ANTIBODY MARKET, BY END-USER

  • Hospital
  • Specialty Clinics
  • Others

GLOBAL BISPECIFIC ANTIBODY MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Bispecific Antibody Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Bispecific Antibody Market Snippet by Product Type
    • 2.1.2. Bispecific Antibody Market Snippet by Application
    • 2.1.3. Bispecific Antibody Market Snippet by Indication
    • 2.1.4. Bispecific Antibody Market Snippet by Country
    • 2.1.5. Bispecific Antibody Market Snippet by Region
  • 2.2. Competitive Insights

3. Bispecific Antibody Key Market Trends

  • 3.1. Bispecific Antibody Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Bispecific Antibody Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Bispecific Antibody Market Opportunities
  • 3.4. Bispecific Antibody Market Future Trends

4. Bispecific Antibody Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Bispecific Antibody Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Bispecific Antibody Market Landscape

  • 6.1. Bispecific Antibody Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Bispecific Antibody Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2022 & 2030 (%)
    • 7.1.2. Blinatumomab
    • 7.1.3. Catumaxomab
    • 7.1.4. Duligotumab
    • 7.1.5. Others

8. Bispecific Antibody Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 8.1.2. Hospital
    • 8.1.3. Specialty Clinics
    • 8.1.4. Others

9. Bispecific Antibody Market - By Indication

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Indication, 2022 & 2030 (%)
    • 9.1.2. Cancer
    • 9.1.3. Inflammatory & Autoimmune Disorder
    • 9.1.4. Others

10. Bispecific Antibody Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Bispecific Antibody Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Bispecific Antibody Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Bispecific Antibody Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Bispecific Antibody Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Bispecific Antibody Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Bispecific Antibody Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Genmab
    • 11.2.2. Merus
    • 11.2.3. Chugai Pharmaceutical
    • 11.2.4. Ablynx
    • 11.2.5. Genentech
    • 11.2.6. Jounce Therapeutics
    • 11.2.7. Affimed Therapeutics
    • 11.2.8. Eli Lilly
    • 11.2.9. AstraZeneca (MedImmune)
    • 11.2.10. Neovii Biotech
    • 11.2.11. Pieris
    • 11.2.12. Adimab
    • 11.2.13. Immunomedics
    • 11.2.14. Roche
    • 11.2.15. Amgen
    • 11.2.16. Sanofi
    • 11.2.17. Emergent BioSolutions
    • 11.2.18. NovImmune SA
    • 11.2.19. Regeneron Pharmaceuticals
    • 11.2.20. EMD Serono
    • 11.2.21. OncoMed Pharmaceuticals
    • 11.2.22. MacroGenicsC

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Bispecific Antibody Market: Product Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Bispecific Antibody Market, by Product Type 2018-2030 (USD Million)
  • TABLE Bispecific Antibody Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Bispecific Antibody Market, by Application 2018-2030 (USD Million)
  • TABLE Bispecific Antibody Market: Indication Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Indication
  • TABLE Global Bispecific Antibody Market, by Indication 2018-2030 (USD Million)
  • TABLE Bispecific Antibody Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Bispecific Antibody Market, by Region 2018-2030 (USD Million)
  • TABLE North America Bispecific Antibody Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Bispecific Antibody Market, by Product Type, 2018-2030 (USD Million)
  • TABLE North America Bispecific Antibody Market, by Application, 2018-2030 (USD Million)
  • TABLE North America Bispecific Antibody Market, by Indication, 2018-2030 (USD Million)
  • TABLE Europe Bispecific Antibody Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Bispecific Antibody Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Europe Bispecific Antibody Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Bispecific Antibody Market, by Indication, 2018-2030 (USD Million)
  • TABLE Asia Pacific Bispecific Antibody Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Bispecific Antibody Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Bispecific Antibody Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Bispecific Antibody Market, by Indication, 2018-2030 (USD Million)
  • TABLE Latin America Bispecific Antibody Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Bispecific Antibody Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Latin America Bispecific Antibody Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Bispecific Antibody Market, by Indication, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Bispecific Antibody Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Bispecific Antibody Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Bispecific Antibody Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Bispecific Antibody Market, by Indication, 2018-2030 (USD Million)